A British news outlet featured UTMB and new research published in the New England Journal of Medicine. "The safety and antibody response of a booster dose administered seven to nine months after the regular two-dose series suggests that a third dose could prolong protection and further increase the breadth of protection against variants," said Pei-Yong Shi, professor in the Department of Biochemistry and Molecular Biology at UTMB.
Data shows greater, broader SARS-CoV-2 neutralizing antibodies with third dose of Pfizer/BioNTech vaccineA third dose of the Pfizer-BioNTech vaccine significantly increased neutralizing antibody levels against SARS-CoV-2, the virus that causes COVID-19, according to new research published in the New England Journal of Medicine.
Dr. Charles Mouton, executive vice president, provost and dean of the School of Medicine at UTMB, wrote: “The COVID-19 pandemic has demanded more from our health care workforce than ever before,” he wrote. “Therefore, it’s especially important to keep patient safety at the forefront of our minds. Health care workers, coping with physical and emotional exhaustion, need the help of everyone to ensure a safe health care environment while they risk their own health to deliver care to others.”
The University of Texas Medical Branch
The University of Texas Medical Branch established in 1891 as the University of Texas Medical Department, has grown from one building, 23 students and 13 faculty members to a modern health science center with more than 70 major buildings, more than 2,500 students and more than 1,000 faculty. more »